Int J Cardiol. 2010 Oct 29;144(3):431-2. doi: 10.1016/j.ijcard.2009.03.048. Epub 2009 Apr 2.
Patients with end stage renal disease on long term dialysis support have a very high risk of sudden cardiac death (SCD) presumably due to serious ventricular arrhythmias. Implantable cardioverter defibrillators (ICD) can be life saving in patients with SCD but their role in dialysis patients is unclear. Much of the current evidence on this important clinical issue limits to retrospective analysis of patients who received an ICD for conventional cardiac indication. It appears that there are certain factors that are unique to patients with renal failure which pre-disposes them to such high incidence of SCD and by applying the conventional risk assessment model on this sub-group of patients we are likely to miss a significant proportion of patients who would not fulfil that criteria but would be at high risk of SCD. In order to clarify this issue, we performed a retrospective screening of patients with end stage renal disease on haemodialysis using conventional risk assessment model and compared the outcome with the known incidence of SCD in this sub-group.
长期接受透析支持的终末期肾病患者发生心源性猝死(SCD)的风险非常高,这可能是由于严重的室性心律失常所致。植入式心脏复律除颤器(ICD)可挽救 SCD 患者的生命,但在透析患者中的作用尚不清楚。目前关于这一重要临床问题的大部分证据仅限于对接受 ICD 治疗常规心脏适应证的患者进行回顾性分析。似乎有某些因素是肾衰竭患者所特有的,使他们容易发生如此高的 SCD 发生率,而如果将常规风险评估模型应用于这组患者,我们很可能会错过很大一部分不符合该标准但 SCD 风险较高的患者。为了澄清这一问题,我们使用常规风险评估模型对接受血液透析的终末期肾病患者进行了回顾性筛选,并将结果与该亚组已知的 SCD 发生率进行了比较。